However, the role of specific ALDH isoforms, such as ALDH1A1, ALDH1A3, ALDH2, and ALDH3A1, as CSC markers has shifted attention towards developing targeted inhibitors to prevent cancer progression. Here, ALDH1A3 is linked to cancer.